Novo Nordisk’s semaglutide product to lose patent protection in China next year, according to L.E.K. Consulting.

A new American Diabetes Association consensus statement provides guidance on screening, diagnosing, and managing metabolic ...

Watsons Philippines gathered the brilliant names in the health, wellness, and beauty industry for its most anticipated annual ...

The large molecule injectable drugs market is anticipated to expand at a CAGR of ~9% during the forecast period. Key drivers ...

Legal battle over semaglutide between Novo Nordisk and Indian drugmakers will set precedent for future opportunities and ...

The global weight-loss drug market is experiencing exceptional growth, projected to expand from around $144.6 billion in 2023 ...

Can artificial intelligence help companies cut food waste and advance one of the most easily achievable climate solutions?

As the U.S. retreats from the World Health Organization, China is partly filling the void. China looks to supplant the U.S.